Moxifloxacin versus ethambutol in the initial treatment of tuberculosis: a double-blind, randomised, controlled phase II trial
Top Cited Papers
- 1 April 2009
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 373 (9670), 1183-1189
- https://doi.org/10.1016/s0140-6736(09)60333-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Confronting the scientific obstacles to global control of tuberculosisJournal of Clinical Investigation, 2008
- Moxifloxacin versus Ethambutol in the First 2 Months of Treatment for Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Outpatient Gatifloxacin Therapy and Dysglycemia in Older AdultsNew England Journal of Medicine, 2006
- Early bactericidal activity of a moxifloxacin and isoniazid combination in smear-positive pulmonary tuberculosisJournal of Antimicrobial Chemotherapy, 2005
- A Nested Case–Control Study on Treatment-related Risk Factors for Early Relapse of TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Moxifloxacin-containing Regimens of Reduced Duration Produce a Stable Cure in Murine TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2004
- Early Bactericidal Activity of Moxifloxacin in Treatment of Pulmonary Tuberculosis: a Prospective, Randomized StudyAntimicrobial Agents and Chemotherapy, 2004
- The Bactericidal Activity of Moxifloxacin in Patients with Pulmonary TuberculosisAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Effectiveness of Once-Weekly Rifapentine and Moxifloxacin Regimens against Mycobacterium tuberculosis in MiceAntimicrobial Agents and Chemotherapy, 2001
- Assessment of New Sterilizing Drugs for Treating Pulmonary Tuberculosis by Culture at 2 MonthsAmerican Review of Respiratory Disease, 1993